CN111670184A - 吡唑化合物及其制备方法 - Google Patents
吡唑化合物及其制备方法 Download PDFInfo
- Publication number
- CN111670184A CN111670184A CN201980011350.9A CN201980011350A CN111670184A CN 111670184 A CN111670184 A CN 111670184A CN 201980011350 A CN201980011350 A CN 201980011350A CN 111670184 A CN111670184 A CN 111670184A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- group
- alkyl radical
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/122—Halides of copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201811003855 | 2018-02-01 | ||
| IN201811003855 | 2018-02-01 | ||
| IN201811003859 | 2018-02-01 | ||
| IN201811003859 | 2018-02-01 | ||
| IN201711042921 | 2018-05-30 | ||
| IN201711042921 | 2018-05-30 | ||
| PCT/IN2019/050076 WO2019150392A1 (en) | 2018-02-01 | 2019-02-01 | Pyrazole compounds and preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111670184A true CN111670184A (zh) | 2020-09-15 |
Family
ID=67478207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980011350.9A Pending CN111670184A (zh) | 2018-02-01 | 2019-02-01 | 吡唑化合物及其制备方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11873289B2 (https=) |
| EP (1) | EP3746434A4 (https=) |
| JP (1) | JP7402804B2 (https=) |
| KR (1) | KR102951622B1 (https=) |
| CN (1) | CN111670184A (https=) |
| AU (1) | AU2019213854C1 (https=) |
| BR (1) | BR112020015692A2 (https=) |
| CA (1) | CA3090204A1 (https=) |
| IL (1) | IL276410B2 (https=) |
| MA (1) | MA54677A (https=) |
| MX (2) | MX2020008151A (https=) |
| MY (1) | MY209060A (https=) |
| SG (1) | SG11202007328UA (https=) |
| WO (1) | WO2019150392A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3090204A1 (en) | 2018-02-01 | 2019-08-08 | MyoKardia, Inc. | Pyrazole compounds and preparation thereof |
| WO2025244956A1 (en) * | 2024-05-20 | 2025-11-27 | MyoKardia, Inc. | Methods of manufacturing danicamtiv |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107428719A (zh) * | 2015-01-22 | 2017-12-01 | 迈奥卡迪亚公司 | 用于治疗扩张性心肌病(dcm)的4‑甲基磺酰基取代的哌啶脲化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284386A (ja) * | 2006-04-18 | 2007-11-01 | Kumiai Chem Ind Co Ltd | ３−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤 |
| US8324178B2 (en) * | 2008-10-31 | 2012-12-04 | The Regents Of The University Of California | Method of treatment using alpha-1-adrenergic agonist compounds |
| EP2714680B1 (en) * | 2011-05-27 | 2015-11-25 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
| BR112015004097B1 (pt) | 2012-08-30 | 2020-02-18 | Bayer Cropscience Ag | Procedimento para a descarboxilação de derivados do ácido 3,5-bis (haloalquil) -pirazol-4-carboxílico |
| CN104968664A (zh) | 2012-12-12 | 2015-10-07 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的并环化合物 |
| EP3063134B1 (en) | 2013-11-01 | 2020-08-12 | Srf Limited | Process for the preparation of pyrazole derivatives |
| EP3015458A1 (en) | 2014-11-03 | 2016-05-04 | Bayer CropScience AG | Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines |
| EP3568390B1 (en) * | 2017-01-10 | 2024-03-06 | Sanford Burnham Prebys Medical Discovery Institute | Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof |
| CN111132964A (zh) | 2017-04-11 | 2020-05-08 | 欧瑞克制药公司 | 糖皮质激素受体调节剂 |
| CA3090204A1 (en) | 2018-02-01 | 2019-08-08 | MyoKardia, Inc. | Pyrazole compounds and preparation thereof |
-
2019
- 2019-02-01 CA CA3090204A patent/CA3090204A1/en active Pending
- 2019-02-01 BR BR112020015692-2A patent/BR112020015692A2/pt active Search and Examination
- 2019-02-01 EP EP19747117.0A patent/EP3746434A4/en active Pending
- 2019-02-01 SG SG11202007328UA patent/SG11202007328UA/en unknown
- 2019-02-01 JP JP2020541983A patent/JP7402804B2/ja active Active
- 2019-02-01 MY MYPI2020003963A patent/MY209060A/en unknown
- 2019-02-01 WO PCT/IN2019/050076 patent/WO2019150392A1/en not_active Ceased
- 2019-02-01 US US16/966,502 patent/US11873289B2/en active Active
- 2019-02-01 MA MA054677A patent/MA54677A/fr unknown
- 2019-02-01 CN CN201980011350.9A patent/CN111670184A/zh active Pending
- 2019-02-01 AU AU2019213854A patent/AU2019213854C1/en active Active
- 2019-02-01 MX MX2020008151A patent/MX2020008151A/es unknown
- 2019-02-01 IL IL276410A patent/IL276410B2/en unknown
- 2019-02-01 KR KR1020207022279A patent/KR102951622B1/ko active Active
-
2020
- 2020-07-31 MX MX2025003379A patent/MX2025003379A/es unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107428719A (zh) * | 2015-01-22 | 2017-12-01 | 迈奥卡迪亚公司 | 用于治疗扩张性心肌病(dcm)的4‑甲基磺酰基取代的哌啶脲化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3746434A1 (en) | 2020-12-09 |
| IL276410B2 (en) | 2024-09-01 |
| IL276410A (en) | 2020-09-30 |
| MX2020008151A (es) | 2020-09-18 |
| US11873289B2 (en) | 2024-01-16 |
| KR102951622B1 (ko) | 2026-04-13 |
| AU2019213854C1 (en) | 2023-12-14 |
| US20210053940A1 (en) | 2021-02-25 |
| SG11202007328UA (en) | 2020-08-28 |
| MX2025003379A (es) | 2025-05-02 |
| MA54677A (fr) | 2021-11-17 |
| MY209060A (en) | 2025-06-18 |
| KR20200118025A (ko) | 2020-10-14 |
| CA3090204A1 (en) | 2019-08-08 |
| EP3746434A4 (en) | 2021-11-17 |
| AU2019213854B2 (en) | 2023-06-15 |
| JP7402804B2 (ja) | 2023-12-21 |
| JP2021512127A (ja) | 2021-05-13 |
| AU2019213854A1 (en) | 2020-09-03 |
| BR112020015692A2 (pt) | 2020-12-08 |
| WO2019150392A1 (en) | 2019-08-08 |
| IL276410B1 (en) | 2024-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI752307B (zh) | 新穎化合物及製造化合物之方法 | |
| CN105658629B (zh) | 用于制备pde4抑制剂的方法 | |
| CN107686471B (zh) | 一种非罗考昔及其中间体的合成方法 | |
| WO2022082329A1 (en) | Processes of preparing 3-fluoro-5- ( ( (1s, 2ar) -1, 3, 3, 4, 4-pentafluoro-2a-hydroxy-2, 2a, 3, 4-tetrahydro-1h-cyclopenta [cd] inden-7-yl) oxy) -benzonitrile | |
| CN108026103A (zh) | 制备细胞毒性苯并二氮杂䓬衍生物的方法 | |
| CN111670184A (zh) | 吡唑化合物及其制备方法 | |
| CN111902396A (zh) | 氨基磺酸锂的制造方法和新型氨基磺酸锂 | |
| CN111704543A (zh) | 用于制备α,ω-二羧酸封端的二烷醚的方法和中间体 | |
| JP3662761B2 (ja) | フェノキシアルキルハライド誘導体の新規製造法 | |
| TWI452040B (zh) | 光酸發生劑之製造方法 | |
| WO2022082337A1 (en) | Process of preparing 3-fluoro-5 ( ( (1r, 2ar) -3, 3, 4, 4-tetrafluoro-1, 2a-dihydroxy-2, 2a, 3, 4-tetrahydro-1h-cyclopenta [cd] inden-7-yl) oxy) benzonitrile | |
| CN102276684B (zh) | 依普利酮的制备方法及其中间体 | |
| HK40027579A (en) | Pyrazole compounds and preparation thereof | |
| EA044890B1 (ru) | Пиразольные соединения и их получение | |
| CN101679301A (zh) | 2-(2-吡啶基甲基)亚磺酰基-1h-苯并咪唑类的制备方法及其中使用的中间体化合物 | |
| CN115286491A (zh) | 一种2-[2-(6-溴己氧基)乙氧基甲基]-1,3-二氯苯的制备方法 | |
| CN116655520A (zh) | 6，6-二甲基-3-氮杂[3.1.0]己烷-2-羧酸类衍生物的制备方法 | |
| WO2012022217A1 (zh) | N-[4-甲基-3-(4-吡啶-3-基-嘧啶-2-基氨基)苯基]苯甲酰胺衍生物及制备方法与在伊马替尼合成中的应用 | |
| CN101316814B (zh) | 采用光反应的维生素d衍生物的制法 | |
| CN101830863B (zh) | 制备PPARδ的配体的方法和用于制备该配体的中间化合物 | |
| TW202311253A (zh) | ３－取代之吡啶鎓化合物的原位合成 | |
| JP2010077077A (ja) | Ｎ−ペンタノイル−ｎ−［２’−（１ｈ−テトラゾール−５−イル）ビフェニル−４−イルメチル］−ｌ−バリンの製造方法 | |
| KR20070090937A (ko) | 2-(피라졸-1-일)피리딘 유도체 | |
| JP2004115476A (ja) | （ｒ）−３−ハロゲノ−２−メチルプロパノールの製造方法 | |
| CN110483392A (zh) | 合成n-保护的喹啉-7-基氧基甲基环丙基胺衍生物的方法及合成中间体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40027579 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |